|
|
|
|
|
|
| MARKET RESEARCH SECTOR IN FOCUS | |
|
|
|
|
|
|
| SEARCH RESULTS |
|
Search Criteria:
Title: Biosimilars
Published Date Range : Any Date
| Page: 1 | 2 Next Last |
Found total 33 records. |
|
|
| Title |
Published  |
Price |
| Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors |
May, 2013 |
$ 2,060.99
|
|
| Biosimilars in Emerging Markets |
Mar, 2013 |
$ 665.00
|
|
| Therapeutic Class Report Overview - Japan Biosimilars |
Jan, 2013 |
$ 1,000.00
|
|
| Competitor Analysis: EGF-R Antibodies – Biosimilars and Biosuperiors |
Dec, 2012 |
$ 257.62
|
|
| Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities |
Nov, 2012 |
$ 3,500.00
|
|
| Competitor Analysis: TNF Antibodies – Biosimilars and Biosuperiors |
Nov, 2012 |
$ 515.25
|
|
| Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors |
Nov, 2012 |
$ 386.44
|
|
| Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors |
Nov, 2012 |
$ 386.44
|
|
| Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors |
Oct, 2012 |
$ 386.44
|
|
| Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region |
Aug, 2012 |
$ 3,500.00
|
|
| Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth |
Jul, 2012 |
$ 3,500.00
|
|
| Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production |
Jun, 2012 |
$ 3,500.00
|
|
| Biosimilars: Global Markets |
May, 2012 |
$ 5,450.00
|
|
| G-CSF Biosimilars Market Forecast to 2015 |
May, 2012 |
$ 291.00
|
|
| EPO Biosimilars Market Forecast to 2015 |
May, 2012 |
$ 291.00
|
|
| HGH Biosimilars Market Forecast to 2015 |
May, 2012 |
$ 291.00
|
|
| Biosimilars and Follow-On Biologics: World Market 2012-2022 |
Apr, 2012 |
£ 1,699.00
|
|
| Global Biosimilars Market Forecast to 2015 |
Mar, 2012 |
$ 1,455.00
|
|
| Biosimilars : Current Situation & Future Prospects, Worldwide |
Mar, 2012 |
$ 2,881.46
|
|
| Global Biosimilars: A return to optimism? |
Jan, 2012 |
$ 2,265.00
|
|
| Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars |
Sep, 2011 |
$ 500.00
|
|
| Global Biosimilars Industry |
Aug, 2011 |
$ 600.00
|
|
| Hospital Injectable Drugs:Future Prospects for Generics & Biosimilars |
Jul, 2011 |
$ 2,265.00
|
|
| Global Biosimilars Market Analysis |
Jul, 2011 |
$ 1,358.00
|
|
| Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues |
May, 2011 |
$ 3,500.00
|
|
| Biosimilars and Follow-On Biologics: World Market 2011-2021 |
Apr, 2011 |
£ 1,499.00
|
|
| Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment |
Apr, 2011 |
$ 3,500.00
|
|
| Biosimilars Update |
Apr, 2011 |
$ 695.00
|
|
| Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars |
Apr, 2011 |
$ 3,500.00
|
|
| Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters and Biosuperiors |
Feb, 2011 |
$ 2,048.11
|
|
Go To Advance Search
|
|
|
|
0 items in cart
